
![]() ![]() Abe and the Beaver...An UpdateUSA Today has some stats on recent campaigns. They called out the sleep aid Rozerem. Check it out here. This is just an update from a blog post a couple months ago about what the drug company behind this ad should do seeing that sales are very far behind the category leaders.
TrackBack URL: http://high.bigwidesky.com/movabletype/mt-neurdependent.cgi/98
|





Strange survey--asking "do you think the ads are effective" is...irrelevant. The audience can speculate all they want, but their judgment of the ad's effectiveness accounts for nothing. You measure effectiveness through results. I might think that one hacksaw cuts steel better than another, but until I actually, y'know, try to cut the metal I don't really know.
One of the biggest challenges Rozerem faces is simply what the article points out from the beginning: there's a flood of sleep-aid stuff available. Probably an excess. Much of it likely useless. The result of these conditions for the humans who buy the stuff is probably confusion, uncertainty, maybe growing indifference. Rozerem came into the game late and spends less money on media placement, and, who's to say that the product is any better than the competition's?
If they want to succeed, they might need to consider something aside from or in addition to a pretty good TV spot. It ain't easy.
Amen brother!